Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL)

1

Review clinical trials related to Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach

PCNS-DLBCL is a rare extranodal non-Hodgkin lymphoma that primarily affects the brain, spine, or vitreoretinal space. The prognosis for PCNS-DLBCL is significantly worse than that for its systemic counterpart. Understanding how and where this tumor initiates, and how it survives or depends on the microenvironment of the CNS is key to understanding the underlying biology and identifying reliable biomarkers for selecting personalized therapy or for biologically directed therapy that could improve the cure rate of CNS lymphomas.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: International Extranodal Lymphoma Study Group (IELSG)Updated: Jun 22, 2026Locations: 2
Eligibility criteria

Be an adult immunocompetent patient who received a PCNS-DLBCL diagnosis accordin... [+2]

Established immunodeficiency conditions. [+2]